MedTrace Logo

Corneal Crosslinking Treatment Study

NCT04427956 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2024-11-22

No results posted yet for this study

Summary

Three different protocols for inducing corneal crosslinks in subjets with progressive keratoconus will be evaluated in this randomised clinical study.

Conditions

  • Progressive Keratoconus

Interventions

PROCEDURE

Corneal crosslinking: CXL (UVA 9mW/cm2)

CXL treatment with UVA-radiation (9mW/cm2) with a 10 minute irradiation protocol.

DRUG

Isotonic riboflavin

CXL protocol with isotonic riboflavin

DRUG

Hypotonic riboflavin

CXL protocol with hypotonic riboflavin

PROCEDURE

Iontophoresis

CXL protocol with iontophoresis and ricrolin

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Ingemar Gustafsson, MD · Region Skåne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-23
Primary Completion
2024-11-19
Completion
2024-11-19

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427956 on ClinicalTrials.gov